Sanofi - SNY (NYSE)

39.75
0.00 (0.00%)
Quotes delayed 15 mins. Currently April 25, 2018 8:05:58 AM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Sanofi researches and develops prescription drugs, vaccines and animal healthcare products

Key Financials

Day Range:39.56 - 40.07
52 Week Range:38.14 - 50.65
Open:39.93
Shares:2.50B
Market Cap:99.23B
EPS:3.73
P/E Ratio:10.60
Div Yield:--
Performance
Previous close
No Chart Available
Purchase SNY in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of SNY not only as a single stock, but also as part of a motif.
Community Motifs with SNY
Common Stock Motif
Common Stock Motif 25.7% 1 YR RTN
Vaccines
Vaccines -- 1 YR RTN
ZIKA VACCINE
ZIKA VACCINE 9.9% 1 YR RTN
View all community motifs with SNY
What Others Think About SNY
JD Alexander
@Pond_Nostalgia & $SGMO now moving onto children who will be the big ultimate benefit of MDS1 MDS2 gene editing sug… twitter.com/i/web/status/9…
1
MM&M Magazine
Missed yesterday's news? Here's everything you need to know. #pharma #marketers #fda #cancer #migraine #apptwitter.com/i/web/status/9…
1
The Lincolnian
Sanofi $SNY Set to Announce Quarterly Earnings on Friday thelincolnianonline.com/?p=1427687
Eleanor Malone
RT @Jessicaemerrill : Zerhouni was a steady hand, pruned the pipeline and pointed $SNY toward biologics, but there were misses too. Most not…
3
Pharma Intelligence
RT @Jessicaemerrill : Zerhouni was a steady hand, pruned the pipeline and pointed $SNY toward biologics, but there were misses too. Most not…
3
Endpoints News
Longtime Sanofi R&D chief Elias Zerhouni is on his way out, handing the research reins to Roche vet John Reed endpts.com/longtime-sanof… $SNY
2
Stock Ratings
RT @StockRatingsHQ : Wednesday, April 25th 2018 - New Buy, Sell or Hold Ratings Issued For:
$PNAT $NCLH $PAY $BGCP $SLCA $DNOW $GDDY $IDCN…
2
Related Companies Within The Drug Manufacturers - Major Sector
JNJ
Pfizer Inc. - 37.06
PFE
Novartis AG - 76.99
NVS
ABBV
AbbVie Inc. - 91.36
ABBV